About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Xth Eurasian Hematology-Oncology Congress
http://www.ehog.net/
Breast
Lung
Hematologic Oncology
Gastrointestinal
Genitourinary
General Oncology
Sarcoma
Skin
Head & Neck
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Optimizing Therapy for ER+ Metastatic Breast Cancer: CDK 4/6 + Endocrine Therapy as 1st Line, Everolimus-Exemestane PI3K as a Reasonable Options for Mutant Patients
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Sema Sezgin Göksu
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Sema Sezgin Göksu
93 views
December 4, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Breast
06:46
Xth Eurasian Hematology-Oncology Congress
Systemic Therapy in Early HER2+ Breast Cancer: More Benefit w/Neoadj…
Feat.
C. Arslan
23:24
Xth Eurasian Hematology-Oncology Congress
Systemic Adjuvant Therapy in Early HER2+ Breast Cancer: Escalating w…
Feat.
C. Arslan
09:24
Xth Eurasian Hematology-Oncology Congress
Evolving Approaches in Systemic Therapy for TNBC in Adjuvant Setting…
Feat.
O. Er
23:29
Xth Eurasian Hematology-Oncology Congress
Systemic Therapy for TNBC in Neoadjuvant Setting: Initial Treatment …
Feat.
O. Er
32:43
Xth Eurasian Hematology-Oncology Congress
Adjuvant Therapy in ER+ / HER2- Early Breast Cancer: Is Chemotherapy…
Feat.
M. Kaplan
15:29
Xth Eurasian Hematology-Oncology Congress
Optimizing Therapy for ER+ Metastatic Breast Cancer: CDK 4/6 + Endoc…
Feat.
S. Göksu
10:36
Xth Eurasian Hematology-Oncology Congress
Overcoming Resistance in HER2+ Metastatic Breast Cancer: Single Anti…
Feat.
S. Uzunoğlu
13:37
Xth Eurasian Hematology-Oncology Congress
Overcoming Resistance in HER2+ Metastatic Breast Cancer: Inhibiting …
Feat.
S. Uzunoğlu
18:51
Xth Eurasian Hematology-Oncology Congress
PARPi as the Emerging Treatment Strategy in BRCA+ Metastatic TNBC: I…
Feat.
O. Dizdar